[Clinical Science] Late-Breaking Clinical Trials 2023 in Asia-Pacific

May 8, 2023, 9:30 AM ~ 10:50 AM | Presentation Theater 1, Vista 3, B2

Moderator(s): Mamas Mamas, Pieter Smits
Panelist(s): Takashi Akasaka, Chee Tang Chin, Carlos Collet, William F. Fearon, Young Joon Hong, Hironobu Kikuchi, James K. Min


  • Aspirin Versus Clopidogrel for Chronic Monotherapy After PCI: HOST-EXAM and HOST-EXAM Extended Study
    Hyo-Soo Kim
  • FFR vs. IVUS to Guide PCI
    Bon-Kwon Koo
  • Intravascular Imaging–Guided or Angiography-Guided Complex PCI: RENOVATE-COMPLEX-PCI
    Joo-Yong Hahn
  • Moderate-intensity Statin + Ezetimibe versus High-intensity Statin Monotherapy in ASCVD: RACING Trial
    Myeong-Ki Hong
  • Panel Discussion I
  • Routine Functional Testing or Standard Care in High-Risk Patients after PCI
    Do-Yoon Kang
  • 10-Year Extended Follow-up of BEST Trial
    Jung-Min Ahn
  • Anticoagulation vs. Antiplatelet After TAVR: ADAPT-TAVR Trial
    Duk-Woo Park
  • Panel Discussion II
Share this Post: